Wang, Jinwan <br/><br/>
Randomized multicenter phase III study of a modified docetaxel and cisplatin plus fluorouracil regimen compared with cisplatin and fluorouracil as first-line therapy for advanced or locally recurrent gastric cancer.  [electronic resource] 

 -  Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association  Jan 2016 
 - 234-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1436-3305 
<br/><br/><label>Standard No.: </label>10.1007/s10120-015-0457-4  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cisplatin--administration & dosage<br/>Docetaxel<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local<br/>Stomach Neoplasms--drug therapy<br/>Survival Rate<br/>Taxoids--administration & dosage<br/>Treatment Outcome<br/>Young Adult